D M Ho1, C Y Hsu, L T Ting, H Chiang. 1. Department of Pathology and Laboratory Medicine, Veterans General Hospital-Taipei, Taiwan, Republic of China. mtho@vghtpe.gov.tw
Abstract
AIMS: We studied the clinicopathological characteristics of plurihormonal pituitary adenomas. METHODS AND RESULTS: The study material included 167 plurihormonal adenomas, which consisted of 31% of the surgically removed pituitary adenomas that we collected during a 12-year period. The mean age of patients with plurihormonal adenoma was 45.7 years (range 13-75 years). There were 86 men and 81 women. All tumours were fully classified by immunohistochemical staining for seven pituitary hormones or subunits. Thirty immunohistochemical subtypes of plurihormonal adenomas were recognized. Hormonal symptoms were present in 70% of patients, while serum hormonal levels were increased in 89% of patients. Most patients had symptoms related to only one of the hormones and only 7% of patients had symptoms related to two hormones. The most common hormonal symptom was acromegaly (50%); symptoms related to hyperprolactinaemia ranked second (20%). Double immunostaining of all the possible combinations of the hormones was performed in 30 selected tumours, and they all showed mixtures of hormones in individual adenoma cells in any hormonal combinations studied. The latter finding supported the view that plurihormonal adenomas are monomorphous adenomas. CONCLUSIONS: Plurihormonal adenomas are common pituitary adenomas. Immunohistochemical staining of all pituitary hormones is mandatory for correct classification.
AIMS: We studied the clinicopathological characteristics of plurihormonal pituitary adenomas. METHODS AND RESULTS: The study material included 167 plurihormonal adenomas, which consisted of 31% of the surgically removed pituitary adenomas that we collected during a 12-year period. The mean age of patients with plurihormonal adenoma was 45.7 years (range 13-75 years). There were 86 men and 81 women. All tumours were fully classified by immunohistochemical staining for seven pituitary hormones or subunits. Thirty immunohistochemical subtypes of plurihormonal adenomas were recognized. Hormonal symptoms were present in 70% of patients, while serum hormonal levels were increased in 89% of patients. Most patients had symptoms related to only one of the hormones and only 7% of patients had symptoms related to two hormones. The most common hormonal symptom was acromegaly (50%); symptoms related to hyperprolactinaemia ranked second (20%). Double immunostaining of all the possible combinations of the hormones was performed in 30 selected tumours, and they all showed mixtures of hormones in individual adenoma cells in any hormonal combinations studied. The latter finding supported the view that plurihormonal adenomas are monomorphous adenomas. CONCLUSIONS:Plurihormonal adenomas are common pituitary adenomas. Immunohistochemical staining of all pituitary hormones is mandatory for correct classification.
Authors: Alice Azzalin; Christina L Appin; Matthew J Schniederjan; Tina Constantin; James C Ritchie; Emir Veledar; Nelson M Oyesiku; Adriana G Ioachimescu Journal: Pituitary Date: 2016-04 Impact factor: 4.107
Authors: Jason L Schroeder; Alejandro M Spiotta; Maria Fleseriu; Richard A Prayson; Amir H Hamrahian; Robert J Weil Journal: Pituitary Date: 2014-04 Impact factor: 4.107
Authors: Wolfgang Saeger; Waldemar Wilczak; Dieter K Lüdecke; Michael Buchfelder; Rudolf Fahlbusch Journal: Endocr Pathol Date: 2003 Impact factor: 3.943
Authors: Nicholas A Tritos; Samatha Eppakayala; Brooke Swearingen; E Tessa Hedley-Whyte; Karen K Miller; Lisa B Nachtigall; Steven K Grinspoon; Beverly M K Biller; Anne Klibanski Journal: Pituitary Date: 2013-09 Impact factor: 4.107